Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4442120
Max Phase: Preclinical
Molecular Formula: C8H17N3O3
Molecular Weight: 203.24
Molecule Type: Unknown
Associated Items:
ID: ALA4442120
Max Phase: Preclinical
Molecular Formula: C8H17N3O3
Molecular Weight: 203.24
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COCC(=N)NCCC[C@H](N)C(=O)O
Standard InChI: InChI=1S/C8H17N3O3/c1-14-5-7(10)11-4-2-3-6(9)8(12)13/h6H,2-5,9H2,1H3,(H2,10,11)(H,12,13)/t6-/m0/s1
Standard InChI Key: ORKFLBDYLQRQJV-LURJTMIESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 203.24 | Molecular Weight (Monoisotopic): 203.1270 | AlogP: -0.61 | #Rotatable Bonds: 7 |
Polar Surface Area: 108.43 | Molecular Species: ZWITTERION | HBA: 4 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 2.13 | CX Basic pKa: 11.29 | CX LogP: -3.12 | CX LogD: -4.83 |
Aromatic Rings: 0 | Heavy Atoms: 14 | QED Weighted: 0.25 | Np Likeness Score: 0.53 |
1. Lunk I, Litty FA, Hennig S, Vetter IR, Kotthaus J, Altmann KS, Ott G, Havemeyer A, Carrillo García C, Clement B, Schade D.. (2020) Discovery of N-(4-Aminobutyl)-N'-(2-methoxyethyl)guanidine as the First Selective, Nonamino Acid, Catalytic Site Inhibitor of Human Dimethylarginine Dimethylaminohydrolase-1 (hDDAH-1)., 63 (1): [PMID:31841335] [10.1021/acs.jmedchem.9b01230] |
Source(1):